David Pascoe

David Pascoe started the Rosacea Support Group in October 1998.

Eucrisa approved for Eczema

Written by on January 16, 2017 in Allergan, eczema, prescriptions with 5 Comments
Eucrisa approved for Eczema

Not strictly a treatment for rosacea, but it is interesting to note that this just-approved drug for the treatment of atopic dermatitis is the first new treatment in 10 years. The way that crisaborole works to inhibit the PDE-4 enzyme active in eczema is not known – sound familiar ? A few proven rosacea treatments […]

Continue Reading

Pulse Light Clinic using Diet with their IPL

Written by on December 19, 2016 in IPL with 1 Comment
Pulse Light Clinic using Diet with their IPL

  A new site sponsor for rosacea-support.org is the Pulse Light Clinic who are located in London. I thank them for their support of the site. Following are some questions that I asked them that you might find intesting if you are considering IPL and also might not have considered the role of professional nutritional […]

Continue Reading

What is Rhofade?

What is Rhofade?

In the coming months you will see more and more references to Rhofade. When a new rosacea treatment launches everyone wants to know what is it ? Asking this question makes sense as we normally only find out the name of a product right at the end of the development process. What we now know […]

Continue Reading

Rhofade approval expected early 2017

Rhofade approval expected early 2017

One little pearl from the Allergan investor presentation is that the company is expecting Rhofade to be approved by the FDA in early 2017. Allergan Plc (AGN) Brenton L. Saunders on Q2 2016 Results – Earnings Call Transcript Aug. 8, 2016 2:03 PM ET About: Allergan plc (AGN) William J. Meury – Chief Commercial Officer […]

Continue Reading

Rhofade is Allergan’s Oxymetazoline

Rhofade is Allergan’s Oxymetazoline

Allergan has confirmed that their Oxymetazoline based treatment due to be released in 2017 will be known as Rhofade. The brand name was confirmed in Allergan’s presentation to investors – Allergan plc Q2 2016 Earnings Presentation – Investor Relations, via the slide shown above. Business analysts are already commenting on their predictions for Rhofade’s success […]

Continue Reading

Top

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.